[From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997].
出版信息
Z Orthop Ihre Grenzgeb. 1997 Nov-Dec;135(6 Suppl):1-4.
PMID:9474258
Abstract
摘要
相似文献
1
[From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997].[从COX概念（环氧化酶-2）到临床获益。美洛昔康树立了标准。1997年9月26日于伦敦召开的全球互动视频会议]
Z Orthop Ihre Grenzgeb. 1997 Nov-Dec;135(6 Suppl):1-4.
2
[Selective cyclooxygenase-2 inhibitor].[选择性环氧化酶-2抑制剂]
Internist (Berl). 1997 Oct;38(10):1007.
3
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.COX-2特异性抑制剂的效果分析及其在临床实践中的应用建议。
J Rheumatol. 2000 Jun;27(6):1338-40.
4
Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.美洛昔康作为抗炎药的药理学特性评估，尤其涉及其对环氧合酶-2相对于环氧合酶-1的相对选择性。
Pharmacology. 1997 Jul;55(1):44-53. doi: 10.1159/000139511.
5
[Rheumatic disease therapy without regret. Meloxicam dosage safety].[无忧的风湿性疾病治疗。美洛昔康剂量安全性]
MMW Fortschr Med. 2002 Nov 14;144(46):66-7.
6
COX-2 inhibitors. Magic bullets or merely mortal?环氧化酶-2抑制剂。神奇子弹还是普通药物？
Harv Health Lett. 2000 Feb;25(4):4.
7
8
Rheumatoid arthritis treatment update.类风湿关节炎治疗进展
Johns Hopkins Med Lett Health After 50. 2000 Jan;11(11):3.
9
The new NSAIDs: cox-2 inhibitors.新型非甾体抗炎药：环氧化酶-2抑制剂
Medsurg Nurs. 2000 Dec;9(6):313-7.
10
Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.即将推出：第二代非甾体抗炎药综述。
J Gt Houst Dent Soc. 1997 Mar;68(8):13-6.
Zotero 插件